Differential (Click to cross reference) advances in neurology adverse drug reaction anticoagulant, complications of anticoagulant, treatment anticoagulant, treatment in CVD aspirin atrial fibrillation atrial fibrillation, nonvalvular atrial flutter atrial septal defect cardiomyopathy cerebral embolism cerebral embolism, cardiac origin cerebrovascular accident cerebrovascular accident, acute management of cerebrovascular accident, prevention of cerebrovascular accident, young adult controversies in neurology cost effectiveness coumarin efficacy hemorrhagic diathesis hepatic failure INR values liver disease liver function enzymes old age, neurology of patent foramen ovale, surgical treatment of platelet inhibiting drugs prevention of neurologic disorders review article safety serum alanine aminotransferase SPORTIF trial thrombin inhibitor thrombus, mural transient ischemic attack treatment of neurologic disorder ximelagatran

Showing articles 0 to 9 of 9 Antithrombotic and Interventional Treatment Options in Cardioembolic Transient Ischaemic Attack and Ischaemic Stroke JNNP 78:14-24, McCabe,D.J.H. &Rakhit,R.D., 2007 Secondary Stroke Prevention With Ximelagatran Versus Warfarin in Patients With Atrial Fibrillation: Pooled Analysis of SPORTIF III and V Clinical Trials Stroke 38:874-880, Akins,P.T.,et al, 2007 Combining Aspirin With Oral Anticoagulant Therapy: Is This a Safe and Effective Practice in Patients With Atrial Fibrillation? Stroke 38:1652-1654, Gorelick,P.B., 2007 Direct Thrombin Inhibition and Stroke Prevention in Elderly Patients With Atrial Fibrillation: Experience From the SPORTIF III and V Trial Stroke 38:2965-2971, Ford,G.A.,et al, 2007 Ximelagatran vs Warfarin for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation JAMA 293:690-698,736, SPORTIF Executive Steering Committee for the SPORTIF V Investigators, 2005 Costs and Effectiveness of Ximelagatran for Stroke Prophylaxis in Chronic Atrial Fibrillation JAMA 293:699-706, OBrien,C.L. &Gage,B.F., 2005 Ximelagatran--Promises and Concerns JAMA 293:736-739, Gurewich,V., 2005 Direct Thrombin Inhibition Stroke 35:1519-1522, Elkind,M.S.V. &Sacco,R.L., 2004 Stroke Prevention with the Oral Direct Thrombin Inhibitor Ximelagatran Compared with Warfarin in Patients with Non-Valvular Atrial Fibrillation (SPORTIF III): Randomised Controlled Trial Lancet 362:1691-1698,1686, Executive Steering Committee on Behalf of the SPOR, 2003 Showing articles 0 to 9 of 9